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Abstract 
Background: Evidence has shown that anthocyanins, a subclass of polyphenol, are metabolised in the gut, 
modulate bacterial species and exert bioactive effects through this interaction. Methods: A systematic 
literature review was undertaken to determine the level of current evidence for the association between 
anthocyanin intake and changes in gut microbiota populations. The studies included were also assessed 
for the different techniques used in microbiota determination. Following the PRISMA (Preferred Reporting 
Items for Systematic Reviews and Meta-Analyses) guidelines, scientific databases, including Scopus, 
PubMed, ScienceDirect, Web of Science and MEDLINE, were searched up to June 2017. Details on 
population/sample, study design, intervention/control, dosage and method of microbiota determination 
were extracted. Results: Six studies (three in vitro, two animal and one human trials) were included in the 
review, which showed that anthocyanins induced a significant proliferative effect on Bifidobacterium spp., 
known for their wide use in probiotics and for the treatment of irritable bowel syndrome. There was also 
an observed inhibition of Clostridium histolyticum, which was shown to be pathogenic in humans. The 
depth of analysis is an important consideration for the choice of microbiota determination technique with 
respect to a comprehensive, high-resolution microbiota analysis or analysis of the main microbiota taxa. 
Conclusions: Very limited research has been carried out in the area of anthocyanins and gut microbiota; 
beneficial effects have generally been observed, and further clinical trials in humans are needed to 
confirm changes to gut microbes in relation to dietary anthocyanin intake and potential health benefits. 
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Context: Evidence has shown that anthocyanins, a sub-class of polyphenol, are metabolised 
in the gut, modulate bacterial species and exert bioactive effects through this interaction.  
Objective: A systematic literature review was undertaken to determine the level of current 
evidence for the association between anthocyanin intake and changes in gut microbiota 
populations. Included studies will also be assessed for the different techniques used in 
microbiota determination.  
Data sources: Following the PRISMA guidelines, scientific databases including Scopus, 
PubMed, ScienceDirect, Web of Science, and MEDLINE were searched up to June 2017. 
Data extraction: Details on population/sample, study design, intervention/control, dosage 
and method of microbiota determination were extracted. 
Result: Six studies (3 in vitro, 2 animal and 1 human trials) were included in this review 
which showed that anthocyanins induced a significant proliferative effect on Bifidobacterium 
spp., known for their wide use in probiotics and for the treatment of Irritable Bowel 
Syndrome (IBS). There was also an observed inhibition of Clostridium histolyticum, which 
have been shown to be pathogenic in humans. Depth of analysis is an important consideration 
on the choice of microbiota determination technique, in regard to a comprehensive, high-
resolution microbiota analysis or analysis of the main microbiota taxa.  
Conclusion: Very limited research has been carried out in the area of anthocyanins and gut 
microbiota; beneficial effects have generally been observed and further clinical trials in 
humans are needed to confirm changes to gut microbes in relation to dietary anthocyanin 
intake and the potential health benefits.  
Systematic Review Registration: PROSPERO registration number CRD42017073750 




Anthocyanins are a group of water-soluble plant pigments responsible for the deep rich 
purple/red/blue colours observed in plant-based foods. They are one of the major subclasses 
of flavonoids, a class of polyphenols. Their role in human health has been established in 
epidemiological studies including improved vision (1), cognition and blood pressure (2, 3), 
and protective effects against cardiovascular disease risk factors (4). 
The metabolism of anthocyanins has been well reviewed (5). Briefly, anthocyanins consumed 
through the diet have shown to be poorly absorbed by the body, with only a small proportion 
of intact anthocyanins able to pass through the gastrointestinal wall using active transporters 
like the sodium-dependent glucose transporter 1 (SGLT1) and facilitative glucose transporter 
2 (GLUT 2) (6). Anthocyanins that are absorbed in the GI tract are mainly found as 
methylated, sulphated or glucuronidated forms but also as intact glycosides in very low 
concentrations in biological fluids such as blood (plasma) and urine (10 to 2000 nM) (5). 
Even though bioavailability of intact anthocyanins in the body is reportedly low, a 
considerable amount of (food) matrix-bound anthocyanins can reach the large intestine and 
the colon. Here they undergo further intensive metabolism and degradation and are absorbed 
into the blood stream, with some of the subsequent metabolites showing potential to be more 
biologically active than the intact anthocyanins (5, 7). The recent interest in the gut 
microbiota and its role in human health has implications for furthering the understanding of 
the effect of anthocyanins on gut microbiota, and subsequent health benefits (8).  
The gut microbiota, which is the microbe population living in the intestine, contain tens of 
trillions of microorganisms, and is made up of at least 1000 different species of identified 
bacteria (9). The majority of the bacteria in the gut are categorised under seven phyla, namely 
Firmicutes, Bacteroidetes, Proteobacteria, Fusobacteria, Verrucomicrobia, Cyanobacteria and 
Actinobacteria with the Firmicutes and Bacteroidetes phyla making up over 90% of the 
human gut microbiota (10, 11). Some of the essential functions of the gut microbiota include 
vitamin production, regulation of lipid metabolism, short chain fatty acid production as fuel 
for epithelial cells and regulation of gene expression (12) as well as an important functional 
role in the  gut-brain axis relationship (13). A heathy gut, which comprises of effective 
digestion and absorption of food, absence of GI illness, normal and stable intestinal 
microbiota, and effective immune status, is required in order to sustain a host homeostasis 
(14). Irregularities and imbalances in the microbiota at different ages have been linked to 
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different diseases and metabolic conditions across the lifespan, ranging from allergies in 
young infants to Inflammatory Bowel Disease in young adults (15). Research on the gut 
microbiota continues to shed light on the health effects of changes to the gut microbiota 
modulated by diet. 
Different techniques have been described for the determination of gut microbiota. 
Advancement in the taxonomical composition of the gut microbiota was limited until the 21st 
century due to bacteriological culture being the only method available to determine its 
composition. Even till date, only about 30% of the gut microbiota has been cultured (10). 
Further understanding of the human gut has been improved by advanced techniques 
independent of bacteriological culture. Prior to these advancements, culture and biochemical 
typing were the gold standards for identification of bacteria species but have now been 
overtaken by methods that are able to produce a more representative information of the 
overall microbiota (16). Examples of some of these techniques are sequencing of the 16S 
rRNA gene or its amplicons, fluorescence in situ hybridization (FISH), quantitative 
polymerase chain reaction (qPCR), denaturing gradient gel electrophoresis (DGGE) and 
terminal restriction fragment length polymorphism (T-RFLP). With these methods 
researchers are able to get qualitative and quantitative information on the diversity of the gut 
microbiota as well as changes in the gut microbiota in relation to an intervention or disease 
(17). Improved scientific methods of gut microbiota determination have also presented the 
issue of suitability of the different techniques used and how the results compare to one 
another. 
Alterations of the gut microbiota have been shown to induce and promote or reduce the risk 
of chronic diseases. This hypothetical mechanism has been applied to the field of obesity and 
obesity-related non-alcoholic fatty liver disease in relation to prebiotics / probiotics (18, 19)  
and anthocyanins (20) as gut modifiers. With this question in mind, given this rapidly 
advancing area of research in gut health, a systematic literature review has been undertaken 
to summarise the current evidence on the effect of anthocyanins on the gut microbiota. The 
included studies will also be assessed for the different techniques used in microbiota 
determination. It is hypothesised that supplementation of the diet with anthocyanin rich foods 
promotes the proliferation of healthy anaerobic bacterial populations, while inhibiting the 




A systematic literature review was conducted according to recommendations of the PRISMA 
(Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement and 
checklist (21) (figure 1 and table S1).  Scientific databases including Scopus, PubMed, 
ScienceDirect, Web of Science, and MEDLINE were searched up to June 2017. A 
combination of search terms with truncations included the following keywords: anthocyanins 
and gut microbiota or colon microbiota (Table 1). The review was registered on PROSPERO 
(International prospective register of systematic reviews) as CRD42017073750 (22). 
Eligibility criteria for included studies (table 2): 
1. carried out either in vitro, on animal or conducted in human subjects; 
2. that quantified the effect of anthocyanin on gut microbial population and described 
the method used; 
3. that utilised anthocyanin extracts or anthocyanin-rich foods with anthocyanin 
(individual compounds or total) content measured and stated; 
4. that assessed changes in gut microbiota associated to anthocyanin metabolism in the 
gut; 
5. reported in the English language for reasons of time efficiency and cost of translation 
not being feasible for this review. 
Exclusion criteria 
Studies were excluded if: 
1. they measured the stability of anthocyanins in the gut without quantifying effects on 
gut microbial population; 
2. there was no measure of anthocyanin content in food/beverage source. One study (23) 
met this criteria but was included because anthocyanin content was measured 
indirectly through the use of anthocyanin metabolites in the urine and was the only 
included clinical trial; 
3. they measured total polyphenols or flavonoids in general and not specifically the 
subclass of anthocyanins. 
Review articles were excluded from the search but were considered for hand searching. Hand 
searching of reference lists was undertaken for all included studies and review articles. All 
selected abstracts and citations were exported from the scientific databases to the reference 
management software ENDNOTE X7 (Thompson Reuters, New York, NY, USA). Following 
extraction and selection of publications according to the above eligibility criteria a tabular  
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summary was developed for this review which included the population, design, intervention, 
anthocyanin dosage, health outcomes and results.  
 
Table 1: Scopus search strategy 
TITLE-ABS-KEY ( anthocyan*  AND  "gut microbiota" )  AND  ( LIMIT-TO ( 
DOCTYPE ,  "ar" )  OR  LIMIT-TO ( DOCTYPE ,  "cp" )  OR  LIMIT-TO ( DOCTYPE ,  
"ip" ) )  AND  LIMIT-TO ( EXACTKEYWORD ,  "Human" )  OR  LIMIT-TO ( 
EXACTKEYWORD ,  "Intestine Flora" )  OR  LIMIT-TO ( EXACTKEYWORD ,  
"Humans" )  OR  LIMIT-TO ( EXACTKEYWORD ,  "Polyphenols" )  OR  LIMIT-TO ( 
EXACTKEYWORD ,  "Metabolism" )  OR  LIMIT-TO ( EXACTKEYWORD ,  
"Polyphenol" )  OR  LIMIT-TO ( EXACTKEYWORD ,  "Article" )  OR  LIMIT-TO ( 
EXACTKEYWORD ,  "Nonhuman" )  OR  LIMIT-TO ( EXACTKEYWORD ,  





The database searches returned 542 articles and one additional study was identified through 
hand searching of reference lists. Following removal of duplicates and screening of records, 
28 full text articles were evaluated and only six studies were eligible and therefore included 
in the review (fig 1). The included studies are summarised in Table 3 and briefly described 
below. 
In vitro studies 
Three in vitro studies were included in this review. Anthocyanins were tested individually or 
in a mixture, in the case of enocianin, a commercial food colouring from Vitis Vinifera grape 
peel which contains a mixture of anthocyanins including malvidin-3-glucoside (200 mg/L 
and 20 mg/L respectively), delphinidin-3-glucoside (60 mg/L and 6mg/L respectively), 
petunidin-3-glucoside (85 mg/L and 8.5 mg/L respectively), peonidin-3-glucoside (traces), 
and cyanidin-3-glucoside (traces). With high and low concentrations reflecting different 
levels of intake, anthocyanins showed proliferative effects on beneficial bacterial population 
and inhibitory effects on pathogenic species. Incubation of malvidin-3-glucoside with human 
faecal slurry at 0 (control), 5, 10 and 24 h, showed a significant, (p<0.05), increase in total 
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bacteria at 24h. Significant proliferative effects were also observed in the bacteria species 
with beneficial effects such as Bifidobacterium spp. and Lactobacillus spp. known for their 
wide use in probiotics and for the treatment of ulcerative colitis, Irritable Bowel Syndrome 
(IBS) and constipation (24). A reduction, although not statistically significant, was observed 
in the potentially harmful Clostridium histolyticum following 24 h incubation. For enocianin, 
a statistically significant increase (p<0.05) was observed in Lactobacillus spp. and 
Bifidobacterium spp. following all incubation durations. Bacterial levels were significantly 
higher than those observed with maldivin-3-glucoside, however, no significant change was 
observed in C.coccoides- Eubacterium rectale group which are known for the critical roles 
they play in immune homeostasis (25) or the pathogenic C. histolycum group (26).  
Similar effects have also been observed with purple sweet potato anthocyanin extracts 
(cyanidins and pelargonidin based anthocyanins) using faecal samples. Following 
fermentation at 0, 6, 12, and 24 h, a significant increase (p<0.05) was observed for the total 
bacterial count. In comparison to the control medium, a steady increase was observed in the 
numbers of the Bifidobacterium spp. following incubation with purple sweet potato 
anthocyanins while a significant increase was observed in the bacterial population of 
Lactobacillus/Enterococcus spp. On the contrary, the control media had a steady increase in 
the Bacteroides-Prevotella and Clostridium histolycum during fermentation, whereas in the 
media containing anthocyanins, levels were significantly reduced (p<0.05).(27)  
On the release, metabolism, and effect on gut microbial growth of cyclodextrin encapsulated 
anthocyanins (cyanidin-3-glucoside, delphinidin-3-glucoside and malvidin-3-glucoside) on 
faecal slurry, between 0 and 24h, malvidin-3-glucoside showed no significant effect on the 
population of Bifidobacterium spp., Clostridium coccoides/Eubacterium rectale group, 
Lactobacillus/Enterococcus spp., C. histolycum group, bacteroides spp., or Clostridium 
cluster IX. However, a significant increase was observed for the members of the domain 
Bacteria (EUBmix probe). Cyanidin-3-glucoside and delphinidin-3-glucoside on the other 
hand showed a significant (p<0.05) inhibition of the C. histolycum group (28). 
All three in vitro studies utilised the FISH technique for enumeration of bacterial populations. 
Animal studies 
Using six different berries (blackberry, blackcurrant, black raspberry, blueberry, Concord 
grape, and maqui berry) with structurally diverse anthocyanin profiles, Overall et. al. (2017) 
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(29) supplemented the diets in a mouse model of polygenic obesity. Anthocyanins from these 
individual berries was normalised to 400µg/g total anthocyanins and supplemented with 
animal chow for each berry category. Six-week old mice were fed LFD (Low-fat diet) or 
HFD (High-fat diet) for six weeks to initiate the development of obesity in the HFD animals. 
Thereafter, the HFD animal group were randomised to different berry supplemented diets for 
a further 12 weeks. Faecal samples were collected from the cages, weighed, and pooled at 
different time points (weeks 4, 8, 9 and 12) and analysed at the end of the study. Using 
quantitative real-time PCR, analysis of the bacterial phyla relative abundance in the faecal 
samples showed that berry supplementation with blackberry and black raspberry did not 
change the gut microbial population shift that was observed with either LFD or HFD. 
Supplementation with Concord grape showed a significant increase of the Actinobacterial 
populations from 2% to 8% in comparison to HFD controls which were similar in kcal/g but 
without anthocyanin supplementation. Blueberry and blackcurrant supplementation also 
showed a significant increase in the populations of obligate anaerobes Bacteroidetes from 7% 
to 10%-12% and Actinobacteria from 2% to 9%-15% which are some of the bacteria species 
beneficial to humans. Translating the anthocyanin consumption in these animal studies to the 
human context , the authors suggested it was equivalent to consuming 2.4 mg/kg/day or 145 
mg/day of total anthocyanins for an average adult (30) which could be achieved by daily 
consumption of 1–2 servings of fresh anthocyanin-rich berries (31). 
Similarly, Lacombe et. al. (2013) (32) examined the effect of dietary supplementation of 
lowbush wild blueberries (LWB) on the colonic microbial population of Sprague Dawley 
rats. Following control diets or LWB-supplemented diets for six weeks, analysis of the colon 
contents of the rats using shotgun sequencing showed a significant reduction in the relative 
abundance of the genera Lactobacillus and Enterococcus associated with the berry 
intervention. There was also a significant (p<0.05) two-fold increase in the relative 
abundance of Bifidobacteriaceae and Coriobacteriacaea and the phylum to which they 
belong, Actinobacteria, in the LWB-supplemented group.  
Human clinical trials 
A randomised crossover clinical trial tested the association between changes in faecal 
microbiota following wine interventions. Nine male participants were randomized to receive 
daily 275 mL of alcoholised red wine or dealcoholized red wine or 100mL of gin for 20 days. 
Participants’ usual baseline dietary habits and pattern and lifestyle were maintained, and 
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additional alcoholic beverages were avoided for the duration of the study. At baseline, and 
following each intervention period, faecal samples were collected from participants. No 
significant differences in daily energy and dietary intake were observed between baseline and 
after each intervention. Quantification of the microbial content of faecal samples was done 
using quantitative real-time PCR. Results showed that in comparison to gin, both red wine 
and dealcoholized red wine significantly (p = 0.001) increased the faecal concentration of 
Bifidobacterium, Enterococcus and Eggerthella lenta. Although the anthocyanin content of 
the red wine intervention used in this study was not measured prior, results showed that the 
lowest to the highest changes in Bifidobacteria tertiles was associated with a higher excretion 
of four phenolic metabolites related to anthocyanin metabolism in participants(23).  
 
Table 2: PICOS criteria for inclusion and exclusion of studies 
 
Parameter Inclusion Exclusion 
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Findings from this systematic review support the hypothesis that consumption of foods high 
in anthocyanins promotes the proliferation of healthy anaerobic bacterial populations, while 
inhibiting the pathogenic species. Specifically, the presence of anthocyanins significantly 
increased the microbial population of Bifidobacterium spp. and Lactobacillus-Enterococcus 
spp. This observation was consistent in in vitro, animal and human studies (23, 26, 27, 32). 
These gram-positive bacteria species have been shown to exert beneficial effects in the 
treatment of diarrhoea and other specific diseases including inflammatory bowel disease 
(IBD), necrotizing enterocolitis and colorectal cancer (33).  
A number of factors including diet, age and antibiotics are important determinants of the gut 
microbiota profile, and the influence of these factors continue to change throughout the 
lifetime (34). The most significant of these factors is diet. In relation to anthocyanin 
consumption, a diet rich in fruit and vegetables has been shown to significantly alter the gut 
microbiota. Even though studies have observed the absence of significant increase in total 
microbial population when samples were incubated with anthocyanins, Zhang, et al. (2016) 
(27) suggested that the absence of this effect could be due to purple sweet potato 
anthocyanins including anthocyanin monomers not being able to affect total bacterial 
population that these purple sweet potato anthocyanins could enhance inhibition and 
proliferation of different species at similar rates. In addition Flores et al (2015) (28) attributed 
this to the amount of anthocyanin used in their intervention study (20mg/L) which could have 
been too low to exert any significant changes. Contrary to these observations, with higher 
concentration (200mg/L) of anthocyanins, Hidalgo et. al. (2012) (26) observed a significant 
(p<0.05) proliferative and inhibitive effect in microbiota population which was more evident 
in samples that were supplemented with a mixture of anthocyanins showing the synergistic 
effect of anthocyanin subclasses. Another possibility is that the observed simultaneous 
proliferative effect on the beneficial bacteria and inhibitory effect on harmful bacteria by 
anthocyanins could explain the absence of any significant change in total bacterial population 
as there exists a natural balance between beneficial and harmful bacteria in the gut (35). 
Even though observations in in vitro models may not be extrapolated to in vivo systems, 
comparison of composition and concentration of anthocyanins across studies which had a 
significant effect on gut microbiota showed that lower concentrations with a variety of 
anthocyanins (Malvidin-, delphinidin-, petunidin-, peonidin- and cyanidin-glycosides) (26) 
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had as much effect as higher concentration with only one class of anthocyanins (cyanidins 
glycosides) (27). Although anthocyanins were not the highest concentration of flavonoids or 
polyphenols in wine (23), it is important to note that anthocyanins, not other polyphenols, 
was associated with the increased level of Bifidobacteria in faecal samples. This was due to 
the observed increase in microbial metabolites in urine presumably derived from 
anthocyanins. The anthocyanin content of all interventions used in the included studies was 
determined using High Performance Liquid chromatography (HPLC) coupled to different 
detectors. HPLC has been identified as the most reliable method of measuring total 
anthocyanin content as well as individual anthocyanins in foods and biological matrices in 
comparison to the colorimetric method that measures only total anthocyanins (36).  
With these observed beneficial effects, the exact mechanism of action of anthocyanins in the 
gut remains unclear, Overall et. al., (2017) (29) observed an increased oxygen tension in all 
gut compartments associated with high-fat diets which was attenuated by supplementing the 
diet with berries and berry anthocyanins. As a result, they suggested anthocyanins may 
reduce oxygen tension in the gut lumen and therefore promote the proliferation of oxygen-
sensitive bacterial population. However, in the small intestine, there exists high level of 
oxygen which limits bacterial growth, such that only fast growing, facultative anaerobes with 
the ability to bind to epithelial/mucus are believed to survive (37). This highlights the 
difference in microbiota composition along the lower GI tract and an important consideration 
in sampling. 
On the issue of sampling, all the studies, but one, included in this review utilised faecal 
samples for the quantification of anthocyanin effects on gut microbiota. In place of faecal 
samples, rectal mucosal biopsy has been proposed as a better alternative in gut microbiota 
research in terms of assessment but not participant burden (38). Durbán et al. (2011) (39)  did 
a comparative study on the bacterial community composition between faecal samples and 
rectal mucosal biopsies. Samples were collected from an un-prepped healthy population. 
Comparison of the two samples showed a significant difference in the bacterial diversity 
between faecal and rectal mucosal samples from the same participant. Another study 
compared healthy subjects to IBS subjects, where they observed that there was a reduction in 
bacterial abundance and diversity in mucosal samples in comparison to stool samples from 
the same participants (40). There is a possibility that significant differences exist in the 
microbial community across the six major subdivisions of the human colon (cecum, 
ascending colon, transverse colon, descending colon, sigmoid colon, and rectum). However, 
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the degree to which composition and functions differ remain unclear. Studying the microbial 
diversity of the human colon, Eckburg et. al. (2005) (10) observed significant inter-individual 
variability and differences between faecal and mucosa community composition. This 
discrepancy highlights the importance of sampling sites and raises the suggestion that rectal 
mucosal biopsy samples are more appropriate than faecal samples and should be used instead 
or together with faecal samples (17). Regardless, faecal samples are still the preferred over 
rectal mucosa biopsy due to ease of collection and being less invasive. 
Another important consideration in gut microbiota research is the methods of determination 
and quantification. Although bacterial culture, which was the gold standard in the past, is 
inexpensive, it produces a limited representation of the gut microbiota diversity and results in 
undervaluation of real changes. Culture independent techniques have become popular and are 
now the most commonly used techniques (41). Most of the different culture independent 
techniques are based on the analysis of the 16rRNA gene. The 16rRNA genes are highly 
protected across bacterial species. They also have distinctive characteristics that allows for 
identification of different species. (17). Studies included in this review employed different 
techniques including FISH, qPCR and shotgun sequencing in the determination and 
quantification of the gut microbiota. These techniques have different pros and cons. The 
qPCR for example, although fast, is unable to identify unknown species and has an 
amplification bias in that the primer set used in multi-template PCR is required to have a 
shared sequence across the targets. As often is the case, this shared sequence is absent in the 
targets. When a primer has one incongruity with some targets, the amplification efficiency is 
significantly reduced and as a result, a large bias in the amplification will occur (42). Even 
though the FISH technique has no PCR bias, it is dependent on probe sequences which mean 
that it is also unable to identify unknown species. The shotgun sequencing on the other hand, 
although more adequate than the aforementioned techniques, is expensive and analysis of 
data involves a complex software (17). The major limitation of the PCR and FISH methods in 
comparison to the shotgun sequencing is their inability to identify unknown species. This 
limitation does not seem to have affected study results as changes in bacteria species were 
measured with already known species hence addressing this limitation. The availability of 
various methods requires deciding the suitability of a given methodology in gut microbiota 
research. This decision will be dependent on the depth of analysis. So far, the shotgun 
sequencing techniques produces the most potent data including projections of microbiota 
function (17). Although a comparative study of 16S amplicon and shotgun sequencing on 
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water samples found that less than 50% of phyla identified via 16S amplicon sequencing 
were recovered from shotgun sequencing while also identifying ~27% more families (43). 
A notable strength of this systematic review is the side by side comparison of different 
methods of microbiota determination as well as effects of anthocyanins. At the time of 
writing this article, to our knowledge, this systematic review appears to be the first to 
determine the effect of anthocyanins on gut microbiota as well as comparing different 
methods of microbiota determination. Another possible strength is the specific focus on 
anthocyanins and their effect on gut microbiota. The synergistic effect of compounds in food 
(nutrients) presents some difficulty in clearly defining causal association in epidemiological 
research. Although nutrients are not consumed in isolation, determining the specific effects of 
particular nutrients is an important aspect of nutrition research.  
As an emerging area of research in the last decade, there are very few in vitro and animal 
studies and even fewer clinical trials that have been carried out. Consequently, there are 
limitations in the comparison of results and generalisation of conclusions due in part to the 
diverse sources of anthocyanins, methods of gut microbiota determination and quantification 
as well as the possibility of synergistic effects of anthocyanins and/with other phytochemicals 
and nutrients present in the food sources resulting in the observed benefits. Another notable 
limitation of this review is the different control diets/samples used which restricts the 
generalisation of results. Although a limitation, it is important to note that these controlled 
samples/diets all had in common the absence of anthocyanins demonstrating the modulatory 
effects of these natural plant pigments. 
It is imperative to advance the understanding of the direct or indirect beneficial effects of 
anthocyanins on bacterial growth through research. It would also be noteworthy to measure 
concurrently these observed effects and identify further anthocyanin metabolites as well as 
other health effects, for example vascular function and cognition to further understand 
complex in vivo processes such as the gut-brain axis relationship.  
 
Conclusion 
In conclusion, research on the gut (microbiota) as a metabolic organ is still emerging and 
characterisation of bacteria species present in the gut is ongoing. Results from this review 
observed beneficial effects such as significant proliferative effect on Bifidobacterium spp., 
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known for their wide use in probiotics and for the treatment of Irritable Bowel Syndrome and 
inhibition of Clostridium histolyticum, which have been shown to be pathogenic in humans  
Research on the possible effect of anthocyanins on gut microbiota population is still in its 
early stages and conclusions and generalisations cannot be made due to the limited evidence 
base and varied techniques employed in studies as well as differences in anthocyanin sources, 
composition, digestive stability, metabolism, biotransformation of anthocyanins in either a 
food matrix or supplement isolated. This also makes it difficult to understand or elucidate the 
exact mechanism of anthocyanins may exert these effects. Therefore, the complete effect and 
exact mode action of anthocyanins on gut microbiota population needs more research 
clarification, in part by conducting more well-designed human clinical trials, reaching a 
consensus on anthocyanin dose and form as well as using a uniform approach to control diets.  




The lead author on behalf of the authorship team affirms that this manuscript is an honest, 
accurate and transparent account of the study being reported and that there has been no 
omission of any important aspects. The reporting of this study was done according to the 
recommendations of the PRISMA (Preferred Reporting Items for Systematic Reviews and 
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